¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"intermediate density lipoprotein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intermediate mesoderm
    Áß°£Á߹迱
  • intermediate nerve
    Áß°£½Å°æ
  • intermediate product
    Áß°£»ê¹°
  • intermediate ray
    Áß°£¹æ»ç¼±
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermediate trait
    Áß°£¼ºÇâ(¼ÒÁú)
  • intermediate-acting insulin
    Áß°£ÀÛ¿ëÀν¶¸°
  • reactive intermediate
    ¹ÝÀÀÁß°£¹°Áú
  • replicative intermediate
    º¹Á¦Áß°£»ê¹°
  • apparent density
    °Ñº¸±â¹Ðµµ
  • asymmetric density
    ºñ´ëĪÀ½¿µ
  • amorphous density
    ¹«Á¤Çü¹Ðµµ
  • bone density
    »À¹Ðµµ, °ñ¹Ðµµ
  • buoyant density
    ºÎ·Â¹Ðµµ
  • coarse reticulonodular density
    °ÅÄ£±×¹°°áÀýÀ½¿µ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermediate spermatogonium
    Áß°£Á¤Á¶¼¼Æ÷
  • intermediate variable
    Áß°£º¯¼ö
  • intermediate cell mass
    Áß°£¼¼Æ÷µ¢ÀÌ
  • intermediate field magnetic resonance scanner
    ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • reactive intermediate
    ¹ÝÀÀÁß°£¹°Áú
  • replicative intermediate
    º¹Á¦Áß°£»ê¹°
  • posterior intermediate sulcus
    µÚÁß°£°í¶û
  • amorphous density
    ¹«Á¤Çü¹Ðµµ
  • apparent density
    °Ñº¸±â¹Ðµµ
  • asymmetric density
    ºñ´ëĪÀ½¿µ
  • bone density
    »À¹Ðµµ, °ñ¹Ðµµ
  • buoyant density
    ºÎ·Â¹Ðµµ
  • coarse reticulonodular density
    °ÅÄ£±×¹°°áÀýÇüÀ½¿µ
  • confluent peripheral density
    À¶ÇÕ¸»ÃÊÀ½¿µ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • LpX lipoprotein
    LpX Áö´Ü¹é
  • plasma lipoprotein abnormalities
    Ç÷ÀåÁöÁú´Ü¹éÁúÀÌ»óÁõ.
  • HDL (High-density lipoproteins)
    °í¹ÐµµÁö´Ü¹éÁú(ÍÔÚËÓøò·Ó±ÛÜòõ)
  • REM density
    ·½¹Ðµµ
  • amorphous density
    ¹«Á¤Çü ¹Ðµµ(ÙíïÒúþ ÚËÓø)
  • apparent density
    °Ñº¸±â ¹Ðµµ.
  • grain density
    ÀÔÀÚ<±×·¡ÀÎ>¹Ðµµ.
  • high electron density
    °íÀüÀڹеµ(ÍÔï³í­ÚËöô).
  • incidence density
    ¹ß»ý ºóµµ
  • innervation density
    ½Å°æÁö¹è¹Ðµµ(¡­ÚËöô).
  • pixel density
    Çȼ¿ À½¿µ, È­¼Ò À½¿µ
  • population density
    Àα¸¹Ðµµ(ÊÙËÑ̬).
  • postsynaptic density
    ¿¬Á¢ÀÌÈÄÄ¡¹ÐÁú
  • presynaptic density
    ¿¬Á¢ÀÌÀüÄ¡¹ÐÁú
  • proton (spin) density
    ¾çÀÚ ¹Ðµµ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lipoprotein
    ÁöÁú´Ü¹é(¡­Ó±ÛÜ)
  • lipoprotein X
    Áö´Ü¹é X
  • lipoprotein deficiency
    Áö´Ü¹é°áÇÌ
  • lipoprotein lipase
  • lipoprotein lipase deficiency
    Áö´Ü¹é¸®ÆÄÁ¦°áÇÌ(Áõ)
  • lipoprotein metabolism
    Áö´Ü¹é´ë»ç
  • plasma lipoprotein abnormalities
    Ç÷ÀåÁöÁú´Ü¹éÁúÀÌ»óÁõ.
  • amorphous density
    ¹«Á¤Çü ¹Ðµµ(ÙíïÒúþ ÚËÓø)
  • apparent density
    °Ñº¸±â ¹Ðµµ.
  • asymmetric density
    ºñ´ëμº À½¿µ
  • bacterial density
    ¼¼±Õ¹Ðµµ(¡­ÚËöô).
  • bone density
    °ñ¹Ðµµ(ÍéÚËöô)
  • buoyant density
    ºÎ·Â¹Ðµµ
  • coarse reticulonodular density
    Á¶ÀâÇÑ ¸Á»ó °áÀýÇü À½¿µ
  • confluent periphilar density
    À¶ÇÕ¼º ¸»ÃÊ À½¿µ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Intermediate lymph nodes
    Áß°£¸²ÇÁÀý
    [¿¾ ¿ë¾î] Áß°£ÀÓÆÄÀý
  • Intermediate cervical septum
    Áß°£¸ñ»çÀ̸·
    [¿¾ ¿ë¾î] Áß°£°æºÎÁß°Ý
  • Intermediate dorsal cutaneous nerve
    Áß°£¹ßµîÇǺνŰæ
    [¿¾ ¿ë¾î] ÁßÁ·¹èÇǽŰæ
  • Intermediate ventral nucleus
    Áß°£¹èÂÊÇÙ
    [¿¾ ¿ë¾î] Áß°£º¹ÃøÇÙ
  • Intermediate part
    Áß°£ºÎºÐ
    [¿¾ ¿ë¾î] Áß°£ºÎ
  • Intermediate part [Red part]
    Áß°£ºÎºÐ
    [¿¾ ¿ë¾î] Áß°£ºÎ
  • Intermediate supraclavicular nerves
    Áß°£ºøÀåÀ§½Å°æ
    [¿¾ ¿ë¾î] Áß°£¼â°ñ»ó½Å°æ
  • Intermediate body
    Áß°£¼Òü
    [¿¾ ¿ë¾î] Áß°£¼Òü
  • Intermediate ganglia
    Áß°£½Å°æÀý
    [¿¾ ¿ë¾î] Á߽ŰæÀý
  • Intermediate atrial branch
    Áß°£½É¹æ°¡Áö
    [¿¾ ¿ë¾î] Áß°£½É¹æÁö
  • Intermediate cuneiform bone
    Áß°£½û±â»À
    [¿¾ ¿ë¾î] Áß°£¼³»ó°ñ
  • Intermediate sacral crest
    Áß°£¾ûÄ¡»À´É¼±
    [¿¾ ¿ë¾î] Áß°£Ãµ°ñ¸ª
  • Intermediate spermatogonia
    Áß°£Á¤Á¶¼¼Æ÷
    [¿¾ ¿ë¾î] Áß°£Á¤Á¶¼¼Æ÷
  • Intermediate spermatogonium
    Áß°£Á¤Á¶¼¼Æ÷
    [¿¾ ¿ë¾î] Áß°£Á¤Á¶¼¼Æ÷
  • Intermediate mesoderm
    Áß°£Á߹迱
    [¿¾ ¿ë¾î] Áß°£Á߹迱
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lipoprotein
    ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • lipoprotein lipase
    ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ) ¶óÀÌÆäÀ̽º
  • lipoprotein tissue factor
    ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ) Á¶Á÷ÀÎÀÚ(ðÚòÄì×í­)
  • low-lipid lipoprotein
    ÀúÁöÁú Áö´Ü¹éÁú(î¸ò·òõò·Ó±ÛÜòõ)
  • very high-lipid lipoprotein
    ÃʰíÁöÁú(õ±ÍÔò·òõ) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • very low-lipid lipoprotein
    ÃÊÀúÁöÁú(õ±î¸ò·òõ) ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ)
  • buoyant density
    ºÎÀ¯¹Ðµµ(Ý©ë´ÚËÓø)
  • charge density
    ÀüÇϹеµ(ï³ùÃÚËÓø)
  • continuous density gradient
    ¿¬¼Ó¹Ðµµ±¸¹è(Ö§áÙÚËÓøÎþÛÕ)
  • density
    ¹Ðµµ(ÚËÓø)
  • density-dependent growth
    "¹ÐµµÀÇÁ¸ ¼ºÀå(ÚËÓøëîðíà÷íþ), (ÔÒ) contact inhibition"
  • density gradient
    ¹Ðµµ±¸¹è(ÚËÓøÎþÛÕ)
  • density gradient centrifugation
    ¹Ðµµ±¸¹è ¿ø½ÉºÐ¸®(ÚËÓøÎþÛÕêÀãýÝÂ×î)
  • density gradient sedimentation equilibrium
    ¹Ðµµ±¸¹è ħ°­ ÆòÇü(ÚËÓøÎþÛÕöØË½øÁû¬)
  • density gradient sedimentation velocity
    ¹Ðµµ±¸¹è ħ°­ ¼Óµµ(ÚËÓøÎþÛÕöØË½áÜÓø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nodular density
    °áÀý¼ºÀ½¿µ
  • perihilar density
    Æó¹®ÁÖÀ§À½¿µ
  • pixel density
    Çȼ¿À½¿µ, È­¼ÒÀ½¿µ
  • proton (spin) density
    ¾çÀڹеµ
  • proton density contrast
    ¾çÀڹеµ´ëÁ¶
  • proton density weighted image
    ¾çÀڹеµ°­Á¶¿µ»ó
  • proton density weighting
    ¾çÀÚ°­Á¶
  • reticular density
    ¸Á»óÀ½¿µ
  • shadow density
    À½¿µ¹Ðµµ
  • spin density
    ½ºÇɹеµ
  • spin density weighted image
    ½ºÇɹеµ°­Á¶¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LDL Low Density Lipoprotein; Àú¹Ðµµ ÁöÁú ´Ü¹éÁú
VLDL Very Low Density Lipoprotein
HDL high-density lipoprotein
HDLBP high-density lipoprotein binding protein
HDL-C high-density lipoprotein-cholesterol
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
Acetyl-LDL Acetylated Low Density Lipoprotein
Ac-LDL Acetylated low density lipoprotein
beta VLDL beta very low density lipoprotein
beta-VLDL beta migrating very low density lipoprotein
LDL E/low density lipoprotein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lateral intermediate substance
    °¡ÂÊ Áß°£ ȸ»öÁú
  • replicative intermediate
    º¹Á¦ Áß°£Çü
  • absolute density
    Àý´ë ¹Ðµµ
  • asymmetric density
    ºñ´ëμº À½¿µ
  • bone density
    °ñ ¹Ðµµ
  • density
    ¹Ðµµ, ÈæÈ­µµ, À½¿µ, ³óµµ
    1. ¹ÐÁýÇϰí ÀÖ´Â ¾ç. 2. ¾î´À ÀÏÁ¤ üÀûÀÇ ¹°ÁúÀÇ ¾ç. 3. Àü±â¹°µµ, Àü·ù¹Ðµµ : ¾î´À ÀÏÁ¤ÇÑ ¸éÀû, üÀû, ½Ã°£³»ÀÇ Àü±âÀÇ ¾ç. 4. ³ë±¤ÀÌ µÇ¾î Çö»óµÈ »çÁø, ¶Ç´Â x¼± Çʸ§ÀÇ Èæ»ö ³óµµ. Çʸ§ÀÇ ÀÏÁ¤ ¸éÀû °ªÀÇ ´ë¼ö·Î¼­ Ç¥½ÃÇÑ´Ù. 5. Áú·® ¹Ðµµ¸¦ ÀǹÌÇÏ¸ç ´ÜÀ§ üÀû´ç Áú·®À» ¸»ÇÑ´Ù.
  • density gradient centrifugation
    ¹Ðµµ±¸¹è ¿ø½É¹ý
    ÃÊ¿ø½É ħ°­ ÆòÇü¹ýÀÇ ÀÀ¿ëÀÌ¸ç Æ¯È÷ »ýü °íºÐÀÚ°èÀÇ ¿¬±¸¿¡ »ç¿ëµÇ´Â ¹æ¹ý. ÀúºÐÀÚÀÇ ¿ë¾×ÀÌ¶óµµ ÃÊ¿ø½É·ÂÀå¿¡ Àå½Ã°£ ³õÀ¸¸é ÀúºÐÀÚÀÇ ³óµµ ºÐÆ÷¿¡ ħ°­ ÆòÇüÀÌ ¹ß»ýÇÏ°í ¾×¸é¿¡¼­ ¹Ø¹Ù´ÚÀ» ÇâÇÏ¿© ³óµµ¸¦ Áõ°¡½ÃÄÑ ÀÏÁ¤ÇÑ ¹Ðµµ °æ»ç°¡ »ý±ä´Ù. ÀÌ ¿ë¾×¿¡ °íºÐÀÚ°¡ Á¸ÀçÇÏ¸é °íºÐÀÚÀÇ Ä§°­°ú È®»êÀÌ ±ÕÇüÀÌ ÀâÈù ħ°­ ÆòÇü°ú µ¿½Ã¿¡ °íºÐÀÚÀÇ ¿ë¾× ³» ¹Ðµµ¿Í ¿ë¸ÅÀÇ ¹Ðµµ°¡ °°Àº Á¸ÀçÇÏ°Ô µÈ´Ù. ±× À§Ä¡¿¡¼­ °íºÐÀÚÀÇ ¿ë¾× ³» ¹Ðµµ¿Í ¿ë¸ÅÀÇ ¹Ðµµ°¡ °°Àº À§Ä¡¿¡ ºÐÀÚ°¡ ÁýÁßÇÏ¿© Á¸ÀçÇÏ°Ô µÈ´Ù. ±× À§Ä¡¿¡¼­ °íºÐÀÚÀÇ ¿ë¾× ¼Ó¿¡¼­ÀÇ ºÎÀ¯ ¹Ðµµ¸¦ ±¸ÇÒ ¼ö ÀÖ°í ±× À§Ä¡¸¦ Áß½ÉÀ¸·Î ÇÑ ³óµµ ºÐÆ÷ÀÇ È®»ê¿¡¼­ ºÐÀÚ·®À» ±¸ÇÒ ¼ö ÀÖ´Ù.
  • density scale
    ³óµµ ´«±Ý
  • electron density
    ÀüÀÚ ¹Ðµµ
    ÀüÀÚÇö¹Ì°æ¿¡¼­ ÀüÀÚÀÇ Åõ°ú¸¦ ¸·À» ¼ö ÀÖ´Â µÎ²² ¶Ç´Â ¹Ðµµ.
  • energy flux density
    ¿¡³ÊÁö¼Ó ¹Ðµµ
  • equilibrium density gradient centrifugation
    ÆòÇü ¹Ðµµ ±¸¹è ¿ø½É¹ý
  • high electron density
    °íÀüÀÚ ¹Ðµµ
    ÀüÀÚµéÀÇ ¹Ðµµ°¡ ³ôÀº °÷.
  • magnetic flux density
    ÀÚ±â À¯µ¿ ¹Ðµµ
  • minimum useful density
    ÃÖ¼Ò À¯È¿ ³óµµ
  • mosquito density
    ¸ð±â ¹Ðµµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
lipoprotein-associated coagulation inhibitor Formerly known as anticonvertin; a protein that inhibits the extrinsic pathway of coagulation by binding to the tissue factor III-factor VII-Calcium-factor Xa complex.
(05 Mar 2000)
lipoprotein electrophoresis Electrophoretic separation of plasma lipoproteins.
(05 Mar 2000)
lipoprotein lipase <enzyme> An enzyme of the hydrolase class that catalyses the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinaemia type I.
Chemical name: Triacylglycero-protein acylhydrolase
Registry number: EC 3.1.1.34
(12 Dec 1998)
lipoprotein lipase deficiency, familial A rare familial condition characterised by massive chylomicronaemia and decreased levels of other lipoproteins. It is due to deficiency of lipoprotein lipase, an alkaline triglyceride hydrolase which catalyses an important step in the extrahepatic removal of triglyceride-rich lipoproteins from the blood.
(12 Dec 1998)
lipoprotein Lp(a) A lipoprotein composed of an LDL particle combined with an additional protein, Lp(a) specific protein; elevated levels have been identified as a risk factor for coronary artery disease.
(05 Mar 2000)
lipoprotein polymorphism Heritable variations in low density beta-lipoproteins; the variant lipoproteins exhibit different antigenic and chemical properties when compared with normal lipoproteins.
(05 Mar 2000)
lipoprotein-x An abnormal lipoprotein which is present in large amounts in individuals suffering from obstructive liver diseases. It exists as a bilayer vesicle of equimolar phospholipids and unesterified cholesterol containing small amounts of plasma proteins (mainly albumin) in its internal aqueous compartment together with some apolipoproteins adsorbed on its surface. Separates with ldl by ultracentrifugation.
(12 Dec 1998)
bone density Bone density is the amount of bone tissue in a certain volume of bone. It can be measured using a special X-ray called a quantitative computed tomogram.
(12 Dec 1998)
bulk density Weight per unit of volume, usually specified in pounds per cubic foot.
(05 Dec 1998)
buoyant density The density that allows a substance to float in some standard fluid.
(05 Mar 2000)
vapor density The mass per unit volume of a vapor; since the vapor density changes with temperature and pressure, it is commonly expressed as a specific gravity, i.e., the weight of the vapor divided by the weight of an equal volume of a reference gas (e.g., oxygen or hydrogen) at the same temperature and pressure.
(05 Mar 2000)
centrifugation, density gradient Separation of particles according to density by employing a gradient of varying densities. at equilibrium each particle settles in the gradient at a point equal to its density.
(12 Dec 1998)
photon density The number of counted events recorded in scintigraphy per square centimeter or per square inch of imaged area.
Synonym: count density.
(05 Mar 2000)
count density The number of counted events recorded in scintigraphy per square centimeter or per square inch of imaged area.
Synonym: count density.
(05 Mar 2000)
population density <epidemiology> Number of individuals in a population relative to space.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • probability density function
    È®·ü ¹Ðµµ ÇÔ¼ö )
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á